CEO Snehal Patel was paid $6,241,685 in fiscal year 2024, ↑ up 127.0% from fiscal year 2023 (SEC filing 0001493152-25-020623 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
$6,241,685 ↑ Snehal Patel total, FY2024 | — CEO pay percentile vs peers | — CEO-to-median pay ratio | — Say-on-pay support, latest vote |
Track this company's pay every filing: join the Pro seat waitlist
Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year
GLSI's next annual pay disclosure, estimated November 3, 2026.est. Filing ↗
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Snehal Patel | $612,563 | $306,281 | $5,322,841 | $0 | — | — | — | $6,241,685 |
| Chief Executive Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2024 total | FY2023 total | FY2022 total | Δ FY2023→2024 |
|---|---|---|---|---|
| Snehal Patel | $6,241,685 | $2,750,028 | — | ↑ +3,491,657 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
You have just read Greenwich LifeSciences's Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper GLSI reports.
We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.
How we handle your data → Privacy
The list of companies that name GLSI as a peer is temporarily unavailable — recheck shortly.
One page per director: the seat, the committees and the fee table, read for one person at a time.
| Director | Role | FY2024 total |
|---|---|---|
| David McWilliams | Chair of the Board | $255,818 |
| Eric Rothe | Independent Director | $170,650 |
| Kenneth Hallock | Independent Director | $170,650 |
No insider equity transactions reported since the proxy statement.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Snehal Patel | Option | 916,320 | 7.63 | — |
| Snehal Patel | Option | 1,048,723 | 12.16 | — |
The Compensation Committee recommends to the Board for approval the overall compensation philosophy for the company and periodically reviews it to ensure it is appropriate and does not incentivize unnecessary and excessive risk taking.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | — |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | true |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2025 | 2025-12-18 | — | — | — | — | — |
| 2024 | 2024-12-19 | — | — | — | — | — |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2025 | 2025-12-18 | —a |
| 2024 | 2024-12-19 | —b |
a. Voting standard not stated in the filing.
b. Voting standard not stated in the filing.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| David McWilliamsIndependent · Board Chair · Audit (Chair) · Compensation (Chair) | $255,818 | $0 | $0 | — | $0 | $255,818 |
| Eric RotheIndependent · Audit · Compensation | 170,650 | 0 | 0 | — | 0 | 170,650 |
| Kenneth HallockIndependent · Audit · Compensation | 170,650 | 0 | 0 | — | 0 | 170,650 |
| Snehal PatelEmployee director | — | — | — | — | — | 0 |
| Annual cash retainer | — |
|---|---|
| Annual equity retainer | — |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | — |
| Stock ownership guideline | — |
| Component | FY2024 |
|---|---|
| Cash retainers and fees | $597,118 |
| Equity awards (grant-date value) | $0 |
| All other compensation | $0 |
| Total cost of the board | $597,118 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Greenwich LifeSciences | 2024 | Snehal Patel | $612,563 | $5,322,841 | $0 | — | $6,241,685 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Snehal Patel | DEF 14A | 2025-11-03 | 0001493152-25-020623 | Section “Executive Compensation”. As printed: 6,241,685. Filing ↗ |
| 2 | Section 08, David McWilliams | DEF 14A | 2025-11-03 | 0001493152-25-020623 | Section “Director Compensation”. As printed: 255,818. Filing ↗machine: span 169617–169624 |
| 3 | Section 08, Eric Rothe | DEF 14A | 2025-11-03 | 0001493152-25-020623 | Section “Director Compensation”. As printed: 170,650. Filing ↗machine: span 170509–170516 |
| 4 | Section 08, Kenneth Hallock | DEF 14A | 2025-11-03 | 0001493152-25-020623 | Section “Director Compensation”. As printed: 170,650. Filing ↗machine: span 171278–171285 |
| 5 | Section 08, Snehal Patel | DEF 14A | 2025-11-03 | 0001493152-25-020623 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 6 | Section 06, 2025 vote | Form 8-K | 2025-12-18 | 0001493152-25-028361 | Item 5.07 · say-on-pay result. As reported: — (votes for as printed: 8,908,299). Filing ↗ |
| 7 | Section 06, 2024 vote | Form 8-K | 2024-12-19 | 0001493152-24-050777 | Item 5.07 · say-on-pay result. As reported: — (votes for as printed: 8,067,672). Filing ↗ |
| 8 | Section 01 trend, Δ column (computed) | Computed | — | — | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 9 | Section 09b board cost (computed) | Computed | — | — | Cash 597,118 + equity 0 + all other 0 = 597,118, summed across the director compensation table rows.machine: formula: Σ = 597,118 |
| 10 | Greenwich LifeSciences (subject), Section 10b CEO total | DEF 14A | 2025-11-03 | 0001493152-25-020623 | CEO total compensation as printed in Greenwich LifeSciences's own proxy. As printed: 6,241,685. Filing ↗ |
The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.
You'll confirm on The Pay Desk's sign-up page.